Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.

For additional information on our guidelines, please visit:  
https://bit.ly/3QyOyt7

Biotechnology

Health Care

Life Sciences

Celltrion Healthcare Co.,Ltd.

Celltrion Healthcare Co.,Ltd.'s headquarters in Incheon, Republic of Korea

Hyoung Ki Kim

Seung Won Seo

Bonnie Zhang

Matt Eddleston

Scottie Jonghoon Kim

Paul Walden

Matthew Sarabura

Kim Sung Min

Andrés Giovanni Monroy Charry

Wonsik Yoo

Kang Kevin

Description

People (5)

Sewan Kim

Seungmin Kim

Sungmo Yang

Scottie Jonghoon Kim

Jooyoung Lee

Jobs